维持性血液透析患者血清内脂素与冠状动脉钙化的相关性研究

doi:10.3969/j.issn.1006-7795.2024.06.020

首都医科大学学报 ›› 2024, Vol. 45 ›› Issue (6): 1095-1099.doi: 10.3969/j.issn.1006-7795.2024.06.020

维持性血液透析患者血清内脂素与冠状动脉钙化的相关性研究

焦建, 王小琪, 邵枫, 袁丹, 李忠心^*

首都医科大学附属北京潞河医院肾病中心，北京 101149

收稿日期:2024-04-24 出版日期:2024-12-21 发布日期:2024-12-19
通讯作者: 李忠心 E-mail:lhyy6806@ccmu.edu.cn
基金资助:
北京潞河医院临床研究项目（LHYY2023-YJZ009）。

A study on the correlation between serum visfatin and coronary artery calcification in maintenance hemodialysis patients

Jiao Jian，Wang Xiaoqi，Shao Feng， Yuan Dan， Li Zhongxin^*

Department of Nephrology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China

Received:2024-04-24 Online:2024-12-21 Published:2024-12-19
Supported by:
This study was supported by Clinical Study of Beijing Luhe Hospital（LHYY2023-YJZ009）.

摘要/Abstract

摘要： 目的探讨维持性血液透析（maintenance hemodialysis，MHD）患者血清内脂素与冠状动脉钙化（coronary artery calcification，CAC）的相关性。方法应用横断面研究法，收集2023年7月1日至2024年2月29日首都医科大学附属北京潞河医院的MHD患者的临床资料，检测血清内脂素水平，应用低剂量胸部多层螺旋电子计算机断层扫描（computed tomography,CT）评估患者CAC情况并分组比较，应用多因素Logistic回归法分析CAC的独立影响因素；应用受试者工作特征（receiver operating characteristic，ROC）曲线分析影响因素对MHD患者发生CAC的预测价值。结果本研究共纳入135例MHD患者，分为无CAC组（n=39）和CAC组（n=96）；2组患者的年龄、合并糖尿病、血清内脂素、血糖、血钠、尿素清除指数（urea clearance index,Kt/V）差异均有统计学意义（P＜0.05）；多因素Logistic 回归分析发现高龄、血清内脂素升高以及合并糖尿病是MHD患者发生CAC的独立危险因素。ROC曲线显示，血清内脂素单独预测CAC的曲线下面积（area under the curve，AUC）为0.751（P＜0.01），具有较高的预测价值。结论血清内脂素升高是MHD患者发生CAC的独立危险因素，可能成为预测CAC的生物学指标。

关键词: 维持性血液透析, 血清内脂素, 冠状动脉钙化, 低剂量胸部多层螺旋电子计算机断层平扫

Abstract: Objective To investigate the correlation between serum visfatin and coronary artery calcification (CAC) in maintenance hemodialysis (MHD) patients. Methods In this cross-sectional study, the general data of MHD patients in Beijing Luhe Hospital, Capital Medical University were collected from July 1, 2023 to February 29, 2024. The serum visfatin level were detected.CAC level was evaluated by low-dose chest multi spiral computed tomography (CT). According to the results of CT, the patients were divided into 2 groups, clinical characteristics were compared between 2 groups, multivariate Logistic regression was used to analyze the independent influencing factors of CAC. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of influencing factors for CAC in MHD patients. Results Totally 135 MHD patients were enrolled in this study and divided into non-CAC group (n=39) and CAC group (n=96).There were significant differences in age, diabetes mellitus, visfatin, blood glucose, serum sodium and urea clearance index(Kt/V) between the two groups (P<0.05). Multivariate Logistic regression analysis showed that older age, higher serum visfatin level and diabetes were independent risk factors for CAC in MHD patients. ROC curve showed that the area under the curve (AUC) of serum visfatin for predicting CAC in MHD patients was 0.751 (P<0.01), which had high predictive value. Conclusions Increased serum visfatin level is an independent risk factor for CAC, and may be a potential biomarker for predicting CAC in MHD patients.

Key words: maintenance hemodialysis, visfatin, coronary artery calcification, low-dose chest multi spiral computed tomography scan

中图分类号:

R543

焦建, 王小琪, 邵枫, 袁丹, 李忠心. 维持性血液透析患者血清内脂素与冠状动脉钙化的相关性研究[J]. 首都医科大学学报, 2024, 45(6): 1095-1099.

Jiao Jian, Wang Xiaoqi, Shao Feng, Yuan Dan, Li Zhongxin . A study on the correlation between serum visfatin and coronary artery calcification in maintenance hemodialysis patients[J]. Journal of Capital Medical University, 2024, 45(6): 1095-1099.

参考文献

［1］ Jansz T T, Go M H Y, Hartkamp N S, et al. Coronary artery calcification as a marker for coronary artery stenosis: comparing kidney failure to the general population［J］. Kidney Med, 2021, 3(3): 386-394.e1.
［2］ Nishizawa Y, Miyata S, Tosaka M, et al. Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients. Sci Rep, 2023,13(1):185-188.
［3］ Xiong L, Chen Q Q, Cheng Y, et al. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients［J］. BMC Nephrol, 2023, 24(1): 238.
［4］ Xiong Y Q, Yu Y, Jiang H, et al. Visceral fat area is a better predictor than coronary artery calcification score for cardiovascular outcomes and All-Cause death in patients on hemodialysis［J］. J Ren Nutr, 2021, 31(3): 306-312.
［5］王小琪, 袁丹, 邵枫, 等. 基于生物电阻抗方法分析血液透析患者内脏脂肪面积与腹主动脉钙化的相关性研究［J］. 首都医科大学学报, 2024, 45(1): 127-132.
［6］ Chang M L, Yang Z, Yang S S. Roles of adipokines in digestive diseases: markers of inflammation, metabolic alteration and disease progression［J］. Int J Mol Sci, 2020, 21(21): 8308.
［7］ Hug C, Lodish H F. Medicine. Visfatin: a new adipokine. Science, 2005,307(5708):366-367.
［8］ Tang X L, Chen M Y, Zhang W R. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease［J］. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2013, 38(6): 553-559.
［9］ Daugirdas J T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error［J］. J Am Soc Nephrol, 1993, 4(5): 1205-1213.
［10］ Berman D S, Arnson Y, Rozanski A. Coronary artery calcium scanning: the agatston score and beyond［J］. JACC Cardiovasc Imaging, 2016, 9(12): 1417-1419.
［11］ An S, Fan R R, Zhao B L, et al. Evaluating coronary artery calcification with low-dose chest CT reconstructed by different kernels［J］. Clin Imaging, 2022, 83: 166-171.
［12］ King S A, Jenkins J D, Livesay J, et al. Coronary artery calcification and risk of cardiac complication in geriatric trauma population［J］. J Am Coll Surg, 2024, 238(4): 762-767.
［13］ Uz O, Kardeşog^∨lu E, Yig^∨iner O, et al. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin［J］. Turk Kardiyol Dern Ars, 2009, 37(6): 397-402.
［14］ Semerena E, Nencioni A, Masternak K. Extracellular nicotinamide phosphoribosyl transferase: role in disease pathophysiology and as a biomarker［J］. Front Immunol, 2023, 14: 1268756.
［15］ Akcabag E, Bayram Z, Kucukcetin I O, et al. Functional effects of visfatin in isolated rat mesenteric small resistance arteries［J］. Eur J Pharmacol, 2021, 908: 174333.
［16］ Muruganandan S, Ionescu A M, Sinal C J. At the crossroads of the adipocyte and osteoclast differentiation programs: future therapeutic perspectives［J］. Int J Mol Sci, 2020, 21(7): 2277.
［17］ Cui L W, Xu J S, Bai Y L, et al. Risk factors for coronary artery calcification in patients with end-stage renal disease［J］. Zhonghua Yi Xue Za Zhi, 2015, 95(38): 3133-3137.
［18］陈燕文, 陈都, 甘春蕾, 等. 维持性血液透析患者血清BMP-2和BMP-4水平与血管钙化的关系［J］. 临床误诊误治, 2021, 34 (8): 91-95.

[1]	张宗玮, 丁国华, 石明. 血清β2微球蛋白浓度与维持性血液透析患者肾性贫血的相关性研究[J]. 首都医科大学学报, 2024, 45(5): 846-852.
[2]	王小琪, 袁丹, 邵枫, 周晶晶, 杨帆, 李忠心. 基于生物电阻抗方法分析血液透析患者内脏脂肪面积与腹主动脉钙化的相关性研究[J]. 首都医科大学学报, 2024, 45(1): 127-132.

维持性血液透析患者血清内脂素与冠状动脉钙化的相关性研究

A study on the correlation between serum visfatin and coronary artery calcification in maintenance hemodialysis patients

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价